PART B: VALORISATION PLAN
SECTION I: ESTIMATION OF COSTS
|
1 |
Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result. |
| … in terms of IPR protection | |
| IPR costs are in total 35.000,00 €, due to IPR cost in Italy (obtained), while the requests for Europe and South Africa are pending.IPR request has been abandoned in USA, China and Australia.
|
|
| …in terms of product development | |
| At least 1 person for 1 year (around 32.000 €) for management of on-field test. | |
| …in terms of mass production | |
| Not applicable | |
| … in terms of marketing | |
| Not applicable | |
|
2 |
Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs |
|||||
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
||
|
Fixed costs |
||||||
|
Personnel |
32.000 |
|||||
|
Other running costs |
||||||
|
Marketing costs |
||||||
|
TOTAL EXPECTED COSTS |
32.000 |
|||||
|
Price per Unit |
||||||
|
Type of Unit |
||||||
|
Number of Units |
||||||
|
TOTAL Expected Revenues |
||||||
|
CASH FLOW REQUIRED (REVENUES-COSTS) |
||||||
|
TOTAL CAPITAL required for five years |
||||||
SECTION 2: QUALITATIVE FACTORS
|
3 |
Dimension of identified target groups |
| Target groups are mainly agro-chemical companies, that can sell the product to wine producers, and wine producers that can buy directly the product. | |
These target groups are very large because Pheronosperal problem has a global dimension, and involve all wine producers.
|
4 |
Evaluation of financial Risks for R&D result |
| Around 30.000,00 € for final definition of a tested and evaluated product. | |
The sum foresees an on-field tests series to realize an evaluation based on and validate the product on real conditions
SECTION 3: IDENTIFICATION OF FINANCING SOURCES
After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)
|
1. European Funding Define relevance of the product with the following potential funding sources and comment |
|
… |
|
2. National Funding |
|
… |
|
3. Private funding |
|
1. … Agrochemical company interested to develop project with on-field tests … |
|
4. Other |
|
|
SECTION 3: FINAL EVALUATION
| It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)… |
| The project result is an antifungal compositions that can be used in both conventional and organic or integrated viticulture with the aim to reduce the copper use (according the new European law about the additional limitation to the copper use in biological viticulture – EC Regulation n. 473/2002 of the Commission of 15 march 2002). |
The advanced stage of product development needs only an on-field testing phase, absolutely necessary to characterize results and to implement a product ready-to-market.
The project, based on the aim to reduce the copper use in agriculture, is interesting for companies that operate in production and marketing of active products against plant pathogens, in particular Plasmopara viticola: the product could be used both in conventional (if synthesized) and in organic or integrated viticulture.
The product is finishing the testing phase and seems to have a great opportunity in the market of grapevine protection from Plasmopara viticola.
Decision of evaluation (Please keep only the appropriate)
- The R&D result needs minor revisions
antonio ferraioli
Fabio Santarossa
